文献速递眼底病与葡萄膜炎

英国糖尿病视网膜病变电子病历用户组报告4:贫困对医院糖尿病眼病就诊表现的真实世界影响

United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.
PubMed 文献 · Br J Ophthalmol · 2018-09-29

结果显示最贫困十分位患者就诊时视力损害(OR 1.29,95%CI 1.20-1.39)和需玻璃体切割(OR 0.34,95%CI 0.19-0.58)的风险更高,提示贫困与糖尿病眼病晚就诊相关。

要点

  • 最贫困十分位患者就诊时视力损害OR为1.29(95%CI 1.20-1.39),高于最不贫困十分位的0.77。
  • 最贫困患者接受玻璃体切割的OR最低,为0.34(95%CI 0.19-0.58)。
  • 最不贫困十分位发生牵拉性视网膜脱离的OR较低(十分位9 OR=0.48,十分位10 OR=0.58)。

核心结论

  • 大型真实世界研究提示,因视力丧失或威胁视力的糖尿病眼病首次就诊于医院眼科门诊与贫困程度相关。
  • 这些首次就诊是接受治疗和正式接触支持服务的首要机会,贫困患者可能需要额外资源以配合复杂治疗方案。

研究设计与样本

  • 多中心、全国性糖尿病视网膜病变数据库研究,从电子病历系统匿名提取22个中心的数据。
  • 基线最小数据集包括年龄和基于居住邮编的贫困指数(Index of Multiple Deprivation),所有时间点包括视力、ETDRS视网膜病变和黄斑病变分级及干预措施(激光、玻璃体腔治疗和手术)。

主要发现

  • 贫困与糖尿病眼病患者更晚就诊相关:进入医院眼科服务时视力损害(较好眼6/18至优于3/60)的OR在最贫困十分位为1.29(95%CI 1.20-1.39),最不贫困十分位为0.77(95%CI 0.70-0.86)。
  • 严重视力损害(较好眼3/60或更差)的OR在最贫困十分位为1.17(95%CI 0.90-1.55),最不贫困十分位为0.88(95%CI 0.61-1.27),参照均为第五十分位。
  • 就诊时威胁视力的并发症和治疗存在差异:最不贫困十分位发生牵拉性视网膜脱离的几率较低(十分位9 OR=0.48,95%CI 0.24-0.90;十分位10 OR=0.58,95%CI 0.29-1.09)。
  • 在治疗可及性方面,最贫困队列接受玻璃体切割的比率最低(OR=0.34,95%CI 0.19-0.58)。

临床怎么用

  • 临床应关注贫困地区糖尿病眼病患者,其首次就诊时更易出现视力损害,可能需要额外资源支持以配合复杂治疗安排。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the impact of deprivation on diabetic retinopathy presentation and related treatment interventions, as observed within the UK hospital eye service. METHODS: This is a multicentre, national diabetic retinopathy database study with anonymised data extraction across 22 centres from an electronic medical record system. The following were the inclusion criteria: all patients with diabetes and a recorded, structured diabetic retinopathy grade. The minimum data set included, for baseline, age and Index of Multiple Deprivation, based on residential postcode; and for all time points, visual acuity, ETDRS grading of retinopathy and maculopathy, and interventions (laser, intravitreal therapies and surgery). The main outcome measures were (1) visual acuity and binocular visual state, and (2) presence of sight-threatening complications and need for early treatment. RESULTS: 79 775 patients met the inclusion criteria. Deprivation was associated with later presentation in patients with diabetic eye disease: the OR of being sight-impaired at entry into the hospital eye service (defined as 6/18 to better than 3/60 in the better seeing eye) was 1.29 (95% CI 1.20 to 1.39) for the most deprived decile vs 0.77 (95% CI 0.70 to 0.86) for the least deprived decile; the OR for being severely sight-impaired (3/60 or worse in the better seeing eye) was 1.17 (95% CI 0.90 to 1.55) for the most deprived decile vs 0.88 (95% CI 0.61 to 1.27) for the least deprived decile (reference=fifth decile in all cases). There is also variation in sight-threatening complications at presentation and treatment undertaken: the least deprived deciles had lower chance of having a tractional retinal detachment (OR=0.48 and 0.58 for deciles 9 and 10, 95% CI 0.24 to 0.90 and 0.29 to 1.09, respectively); in terms of accessing treatment, the rate of having a vitrectomy was lowest in the most deprived cohort (OR=0.34, 95% CI 0.19 to 0.58). CONCLUSIONS: This large real-world study suggests that first presentation at a hospital eye clinic with visual loss or sight-threatening diabetic eye disease is associated with deprivation. These initial hospital visits represent the first opportunities to receive treatment and to formally engage with support services. Such patients are more likely to be sight-impaired or severely sight-impaired at presentation, and may need additional resources to engage with the hospital eye services over complex treatment schedules.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Denniston AK, Lee AY, Lee CS, et al. United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services. Br J Ophthalmol. 2018. PMID: 30269098. doi:10.1136/bjophthalmol-2018-312568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。